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Abstract
Intentional and unintentional medication non-adherence is a particular challenge for patients with inflammatory bowel disease
(IBD). Non-adherence can affect patients’ quality of life, which can result in unfavorable treatment outcomes, more hospitali-
zations, and higher healthcare-related costs. The purpose of this study was to assess whether a tailored text message intervention
designed to modify illness and medication adherence beliefs in patients with IBD would increase treatment compliance and
change patients’ illness perceptions and medication concerns. This pilot study utilized a pre-test-post-test non-randomized
design. A sample of 32 IBD patients was recruited within the UK. Participants’ medication beliefs and illness perception scores
determined the set of tailored daily text messages, which were sent to patients over duration of 12 weeks. Medication adherence
increased post-intervention, as Bforgetting to take medication^ decreased while Bnever^ forgetting to take medication increased
over time. A significant increase in treatment control and coherence and a decreased level of concern surrounding their condition
was evident. Participants’ level of concern towards their medications changed during the 12 weeks, with a baseline mean concern
score of 3.08 (.57) in comparison to the 12 weeks mean concern score of 2.89 (.59), which is statistically different, t (31) = 2.16,
p < .038, r = .36 (medium effect). Sixty-six percent of participants from the baseline were aware of the necessity of their
medication: Bwithout my medication I would become ill.^ The results have direct implications for improving medication
adherence and changing illness and medication beliefs. This study validated the benefits of text messages and highlighted the
importance of addressing these beliefs in order to understand the reasons for non-adherence fully.
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Inflammatory bowel disease (IBD) is used to describe two
conditions which are characterized as chronic and lifelong:
Crohn’s disease and ulcerative colitis (NHS Choices 2017).
These idiopathic conditions affect around one in 250 people
living within the UK, and are not gender-specific (Crohn’s and
Colitis UK 2012). Although these conditions are not curable,
treatment to manage the symptoms is frequently offered to
patients. However, adherence is not always optimal, and pa-
tients with IBD go through stages of maintenance (when the
inflammation reduces and the pain subsides) where they begin
to feel better, and this is usually when noncompliance to their
medication may begin (Broide et al. 2017). Despite the long-
term benefits of these medications, a commitment to adhering
to the medication regimen is challenging for most IBD suffers,
and may not always take priority. The consequences of miss-
ing a dose can be detrimental, and is attributed to build-up
over time, increasing disease progression.
The fundamental issues related to non-adherence are
compounded by the complex nature of human behavior.
Although the term Badherence^ commonly refers to the phys-
ical act of taking medicine, its definition encompasses more
than just the patient’s response towards medication, but in-
stead takes into account the whole treatment experience.
Horne et al. (2005) found that patients need to be supported
throughout the experience, covering prescription, collection,
and administration. Furthermore, they highlight that
Bstipulating unconditional and unquestionable adherence to
prescribers’ instructions as our goal, in most cases, is not jus-
tified if the patient has not made an informed choice about
taking their medication^ (Horne et al. 2005, p. 37).
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In a study by Ediger et al. (2007) explained that non-
adherence to treatment can also be a result of the patient’s
experience with medication, irrespective of gender.
Ardizzone et al. (1999) found a link between drug palatability
and drug formulation, which resulted in difficulties in
swallowing the tablet, the dislike of loose powder, and unman-
ageable general or specific side effects of the medication, such
as pain or abdominal discomfort. Similarly, D’inca et al.
(2008) found that a significant reason for low treatment com-
pliance to IBD medication was the high-dose expectation and
complex regimen which required patients to take medication
three times a day at specific time points. Other indicators of
non-adherence were due to a lack of understanding of how
and when to take the medication, skepticism about drug effi-
cacy and safety, and forgetfulness (Engel et al. 2017).
Patients may not always be able to assess consciously the
beneficial factors of taking their treatment as prescribed.
Despite the fact that the benefits of adhering is associated with
better overall health outcomes (Horne et al. 2005).
Compliance to medication and the complicated relationship
people develop regarding their diagnosis will differ for every
individual: some may be very adherent, while others may be
less. In the event that some are not compliant, there is a need to
understand their reasons, which may not always be clear.
Illness Perception and Medication Beliefs
Leventhal et al. (1992) introduced the common-sense model
(CSM) of illness representation, which suggests that patients’ be-
liefs surrounding their illness are integrated within existing
schemas, which enable them to understand their condition and
adopt coping strategies. The model consists of five components:
(1) identity (thename/labelgiven to the symptomsandconditions,
which will differ for each patient’s perceptions), (2) cause (the
personal adopted ideas as to the etiology of the condition, based
on information gathered from personal experiences and health
professionals), (3) timeline (the beliefs surrounding the duration
of the condition, which are interchanging over the duration of the
condition), (4) consequence (the beliefs surrounding how their
condition will impact on their life, particularly the physical and
social aspects), and (5) curability/controllability (the beliefs about
whether this condition can be controlled or cured).
Leventhal et al. (1992) state that each patient develops an
individualistic view that serves as the foundation of the illness
beliefs, which change over time. The perceptions will evolve
from the start of a diagnosis, while the individual is learning
more about the condition and ways to cope. During this pro-
cess, new representations are formed along the way, and these
transition into the patient’s schemas. This, in turn, contributes
to our understanding of how and why patients develop per-
sonal beliefs surrounding their medication and the ways in
which they view their treatment pathway. For this reason,
patients with the same condition can hold disparate views
surrounding their illness, which may explain why some pa-
tients are adherent to their medication regimen and others are
not (Fig. 1).
Illness Perception/Medication Beliefs and IBD
The multifactorial nature of medication adherence depends very
much on how the patients perceive the benefits of their
treatment, and on their understanding of the diagnosis. Kane
and Shaya (2008) found that around 60% of patients fail to
adhere to their prescribed medication dose, and around 70% fail
to take their prescribed medication. Often, adherence research
specific to IBD has found that patients become non-adherent
when they begin to question the need for medication, particu-
larly during periods of remission (Kane and Shaya 2008).
Similarly, the fear of developing an addiction to the medication
limits willingness to comply with planned treatment (Lesnovska
et al. 2010). Horne et al. (2009) found that non-adherence to
maintenance therapy was due to beliefs associated with the
Bneed^ for therapy and the potential adverse effects of long-
term treatment. Therefore, understanding what these pre-
conceived beliefs are—and then offering an interventional ini-
tiative which seeks to address these beliefs—should elicit
change. Better understanding and knowledge about the treat-
ment journey can increase patients’ self-efficacy in managing
their illness and can highlight any pre-existing illness beliefs and
medication concerns, which, in turn, supports increased compli-
ance (Lenti and Selinger 2016).
The new generation of health interventions is moving to-
wards digitized innovative methods that seek to support peo-
ple in managing their health conditions more effectively.
Interventions delivered through mobile platforms are increas-
ing rapidly. We do not understand the long-term benefits of
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Fig. 1 Consort diagram for the IBD TMI pilot study—illustrates the
pathway of recruitment which led to the end of the research study
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these mobile interventions and how they can change health
behaviors, however. Research measuring the success of text
messaging interventions (TMIs) has been published since
2002, with the first study of this kind focusing on mobile
messaging and asthma (Neville et al. 2002). Since 2002, there
have been a number of papers testing the impact of text mes-
sages as part of a health intervention, or as a standalone tool
(Gerber et al. 2009; Franklin et al. 2006; Fjeldsoe et al. 2009).
These studies have found promising results and have shown
that TMIs are targeting a variety of health conditions such as
weight loss (Gerber et al. 2009) and chronic health conditions
such as asthma and diabetes (Franklin et al. 2006; Petrie et al.
2012).
TMIs are noticeably low-cost and adaptable, and the con-
tent of the messaging is quite flexible. This simple but sophis-
ticated method has the capacity to reach a multitude of people
across the globe. In addition, TMIs have a number of qualities
such as offering personalized, time-specific messages, and the
ability support reinforcement through repetition. Furthermore,
this method can be significantly effective for those who use
their mobile device frequently and enjoy communicating via
this process (Hall et al. 2015). Mobile statistics have shown
that 99% of sent text messages are opened, while 90% of all
mobile text messages are read within 3 min of being received
(Hall et al. 2015). Therefore, we can assume that sending
health messages via this mode of communication will be ac-
cessible, effective, and measurable.
TMIs can be relatively successful, but developers should
be mindful of how they deliver the messages. A recent review
found that interventions that used personalized messages and
messages of unpredictable frequency over the course of the
interventions were more successful than interventions that of-
fered a fixed messaging frequency (Head et al. 2013). This
finding was similar to Vervloet et al. (2012) systematic review.
This review specifically focused on the effectiveness of elec-
tronic reminders such as SMS, audio/visual reminders, pagers,
and beeper systems. Within this critical review, non-adherent
patients became adherent over time in all but two of the 13
studies. The two that were not successful were due to the
frequency of the messages, as weekly reminders were deemed
more appropriate than daily. The significance of reminder
messages was ignored when reminders were sent daily, re-
gardless of whether the patient had already taken their medi-
cation or not. Vervloet et al. (2012) argue that sending daily
reminders develops a habituated attitude, which has a negative
influence on the patient.
Studies evaluating IBD adherence to medication using be-
havioral interventions focusing on self-management tech-
niques via SMS have found that TMIs, when offered to pedi-
atric IBD patients, resulted in a significant increase in medi-
cation adherence over a period of 6–12 months. The modified
text messages sent to patients were simple, short messages that
only targeted adherence to medication and not illness beliefs
or medication concerns (Keefer et al. 2011). This translates
into other chronic conditions, as established in DeKoekkoek
et al. (2015) review. They found 13 published TMI studies that
have all validated the benefits of text messaging as an inter-
vention to improve medication adherence across different
chronic conditions, besides IBD.
The aim of this study was to evaluate the feasibility and
acceptability of a mobile text messaging intervention aimed to
increase adherence in people living with IBD. The objective
was to evaluate the suitability of the intervention and to pro-
vide a preliminary evaluation of responses to the intervention.
It was hypothesized that participants will show changes in
their illness and medication beliefs, as well as improved ad-
herence to their medication.
Methods
Study Design
The research design for this pilot study was a pre-test-post-test
non-randomized design. Specifically, the research design was
a within-subject design, which consisted of two time points
(baseline and 12weeks). All of the study participants took part
in the same interventional offering in terms of frequency of
messages. The independent variable was the use of tailored
text messages specific to the participants’ beliefs, which were
pre-defined from the questionnaire measurements. The study
measured the difference in adherence to medication, changes
in illness perception, and medication beliefs (dependent
variables).
Participants
The target population for this pilot study consisted of partici-
pants from across the UK. The sample for this study was made
up of adults who have a diagnosis of inflammatory bowel
disease (IBD), aged 18 years and older, and who volunteered
to participate in the 3-month study. Participants were required
to have access to a mobile phone.
Participant Recruitment
Study participants were recruited via study adverts that were
distributed around a university campus and local GP surgeries.
Participants were also recruited via paid advertisement on
popular social media sites. Facebook was chosen as the main
recruiting site, as it has open access to the public and billions
of daily users. A website domain was purchased and devel-
oped to assist potential participants in enquiring about or en-
rolling onto the study (www.crohnsdiseasestudy.org.uk). The
designated website included relevant information for the study
and directed participants to self-enroll by prompting them to
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complete an BI’m interested^ form. Once completed, an email
notification was sent to the researcher, who then emailed the
consent form and participant information sheet to interested
participants. The preloaded consent form, information sheet,
and information related to the study were also found on the
website. Using the CONSORT process, the recruitment lasted
for approximately 2 months (January 2014 until March 2014).
There was a high number of interested participants at the
beginning of the recruitment phase of this project (n = 122).
Of the 122 who completed the BI’m interested^ form, 32
signed and returned the consent form and completed the pre-
questionnaire. Ninety potential participants did not respond to
the invitation, accounting for an overall 26% recruitment rate.
On completion of the study, all 32 participants completed the
post-questionnaires. There were no incentives offered to
participants.
Data Collection
The data collection process was accomplished in two phases,
once at the beginning of the study, and once again at the end of
the study. Validated questionnaires which have been tested for
reliability were administrated at both time points (pre and
post). Below is the outline of each questionnaire and scoring
mechanism.
The Demographic Data Questionnaire was created by the
researcher and collected basic medical history, age, gender,
year of diagnosis, ethnicity, and medication usage.
The Brief Illness Perception Questionnaire (BIPQ;
Broadbent et al. 2006) measured how a patient perceives their
illness. The sub-constructs of illness perception cluster around
five significant themes: identity, cause, timeline, conse-
quences, and cure control. The following are some examples
related to the sub-constructs: BIdentity^—Bhow much does
your illness effect your life?^ (0 = Bno effect at all^ and 10=
Bseverely effects my life^) and BTimeline—Bhow long do
you think your illness will continue?^ (0 = Ba very short time^
and 10 = ‘forever’). Each item is scored on an 11-point Likert
scale. Total scores for this questionnaire were calculated by
summing the item scores together and reverse scoring items 3,
4, and 7. A higher total score reflects a more threatening view
of the illness, whereas a lower score indicates benign illness
representation. The BIPQ has shown good test-re-test validity
in six illness group psychometric properties, and has been
shown to measure patients’ cognitive and emotional represen-
tation of their illness, including consequences, timeline, per-
sonal control, treatment control, identity, coherence, concern,
emotional response, and causes (Broadbent et al. 2006).
Beliefs About Medication Questionnaire (BMQ; Weinman
et al. 1996). BMQ assesses both the general and specific med-
ication beliefs of a participant. The objective of this question-
naire is to help the researcher understandwhy some people fail
to adhere to their medication by learning about their
medication perception. The BMQ is divided into two sections:
BMQ-General (sub-scales: Overuse and Harm, 4 items per
sub-scale) and BMQ-Specific (sub-scales: Necessity and
Concerns, 5 items per sub-scale). The specific section assesses
patients’ beliefs about medications prescribed for an illness
and comprises two scales assessing personal beliefs about
the necessity of medication prescribed for controlling their
illness. Sections included Bmy health at present depends on
my IBD medicine^ (5 statements) and concerns about the
potential adverse consequences of taking it, i.e., BI sometimes
worry about becoming too dependent onmy IBDmedication^
(5 statements). Each statement has 5-point Likert scale an-
swers (strongly disagree, disagree, uncertain, agree, and
strongly agree). The answers are scored from 1 = Bstrongly
disagree^ to 5 = Bstrongly agree,^ and the points of each scale
are summed to give a scale score. Higher scores indicate stron-
ger beliefs in the concepts of the scale (high/low necessity and
high/low concern).
The Adherence Measure (Morisky et al. 1986) measured
levels of medication adherence. Using one item question from
the 4-item questionnaire, the adherence measure was present-
ed to participants through the following question: BHow often
do you forget to take your medication?^ Participants were
asked to rate their level of adherence on a scale of 1 (Bnever^)
to 6 (Bvery often^). The question was adapted from the vali-
dated Morisky Medication Adherence Scale (MARS). For the
purposes of this study, the interest lay in understanding how
often patients would forget to take their medication, as op-
posed to learning about the other variables within this measure
(Morisky et al. 1986).
Procedure
Once the initial questionnaires were completed and received
by the researcher, the information was logged and an email,
and Btest^ text message were sent to the participants to con-
firm that their number was working and that they could re-
ceive text messages from the program number. Participants
were prompted to reply to the email and to confirm their re-
ceipt of the message. Over the course of the12 weeks, partic-
ipants were sent tailored text messages based on their baseline
BIPQ and BMQ scores. Messages were selected randomly—
but specific to each BIPQ scores—and participants who
scored high or low on each of the targeted beliefs were sent
messages from that category. If participants did not score high
or low in the target beliefs, they were not sent text messages
relating to that belief. The frequency of these messages dif-
fered over the 12 weeks (illustrated in Table 1). A completed
template of messages which included allocated times for each
message was preloaded onto a text messaging program every
week in order to ensure accuracy of messages, and this was
checked by the researcher on a weekly basis prior to the mes-
sages going out to participants. At the end of the 12 weeks,
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participants were prompted to repeat the pre-screener ques-
tionnaires, including the BMQ, BIPQ, and the adherence
scale. Pre-and post-scores were used to measure the efficacy
of the program.
Text Messages—Process Plan
Table 1 outlines the frequency of text messages sent to partic-
ipants. There was a decrease in messages sent from weeks 4–
8, with an increase to three messages per day from weeks 8–
12. The frequency differed to allow participants to manage the
informational load and engage with the study, instead of feel-
ing overwhelmed with a continuous set of messages.
Participants received targeted, tailored text messages related
to their illness and medication beliefs. Each belief consisted of
seven messages, giving a total of 112 messages. The aim of
the messages was to address participants’ prior illness and
medication beliefs relating to their condition (Tables 2 and 3).
Analytic Strategy
The data were analyzed using the statistical package SPSS
version 22 (SPSS Inc.). Based on the aims of the research,
changes in illness perception scores pre- and post-process
were compared using a parametric paired sample t test. This
was to test for any significant differences in participants’ ill-
ness perceptions within the sample group over the period of
3 months. In order to use the t test, the assumptions were met,
ensuring that the data was normally distributed, the variance
between the groups were equal, and the sample size was ade-
quate (at least 30 cases).
The research aimed to measure a change in participants’
medications beliefs (necessity and concern) over 3 months,
and a paired sample t test using the scores (pre/post) was
conducted to examine the mean differences within the group.
In addition, participants did not drop out of the study over the
3 months. The final complete data set did not include any
missing data.
Although this is a pilot study, the post-screener offered
space for participants to include qualitative feedback of their
experience if they had any additional insight or recommenda-
tions regarding the acceptability and suitability of the
intervention.
Sample Size
Lancaster et al. (2004) recommend that the sample size for a
pilot study should be 30 participants. Other evidence has sug-
gested that a sample size between 24 and 50 participants is
justifiable for such a study.
Results
The study sample consisted of 32 participants with a mean age
of 42 years all of whom completed pre- and post-question-
naires. Out of the 32 participants, 39%were white British, and
68% females. Demographic characteristics of study partici-
pants are shown in Table 4.
Medication Adherence
Self-reported adherence was measured at baseline and at the
end of the 12 weeks. Participants were asked Bhow often do
you forget to take your medication?^ Figure 2 below illus-
trates the pre- and post-process self-reported medication ad-
herence scores per participant over the 3 months. A total of 32
participants rated how often they forgot to take their medica-
tion on a scale of 1–6 (1 = never and 6 = very often).
Medication adherence increased post-intervention, as
Bforgetting to take medication^ decreased while Bnever^ for-
getting to take medication increased over time. The rate of
self-reported adherence at pre-intervention was 1 (3.1%) and
there was an increased level of change over 3 months, with the
Table 1 Frequency of text messages
Duration Frequency of messages
Weeks 1–4 2 text messages per day
Weeks 4–8 1 text message per day
Weeks 8–12 3 text messages per day
Table 2 IPQ—extracts of the different text messages which were sent to participants
IPQ scale Example text messages
Low identity (low symptoms) BComing off your medication is likely to worsen your symptoms^
High identity (high symptoms) BAbdominal pain, diarrhea, weight loss, and bloody stools can be managed if you follow your treatment plan,
this will improve your symptoms.^
Low consequences BCrohn’s disease is a condition that needs regular care and attention.^
High consequences BManaging your Crohn’s disease means getting on with life.^
Short timeline BYour Crohn’s disease is always there even when you do not have symptoms.^
High timeline BYour Crohn’s Disease will always be there but you can learn to manage it and accept it.^
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rate of adherence at 11 (34.4%) at the 3-month interval. This
suggests that the tailored text messages increase medication
adherence.
Illness Perception
There was no overall significant difference in illness percep-
tion, but significant changes occurred in three categories of the
IPQ: concern, coherence, and treatment control. A paired sam-
ple t test reported an increase in treatment control and coher-
ence, and a decreased level of concern surrounding their con-
dition. This analysis shows that text messages did change the
beliefs in a direction consistent with an increase in adherence.
The paired sample t test indicated a significant change in
the data set when comparing pre- and post-intervention mean
IPQ scores. In particular, there was a change in concern at
baseline (M = 7.53, SD = 2.1), and at 12 weeks, (M = 6.66,
SD = 1.8) which was significantly lower post-intervention,
with t = (31), 2.35, p < .025. This was the same for coherence,
at baseline (M = 3.09, SD = 1.9) and at 12 weeks (M = 6.53,
SD = 3.0), and was significantly higher post-intervention,
with t = (31), − 5.63, p < .001. Finally, treatment control at
baseline (M = 3.91, SD = 1.9) and at 12 weeks, (M = 6.72,
SD = 1.9) was significantly higher at 12 weeks, with t = (31),
− 6.04, p < .001. There was no significant change in conse-
quences, identity, timeline, and emotional representation.
Medication Adherence
Descriptive Statistics
The baseline means concern score of 3.08 (.57) in comparison
to the 12-week mean concern score of 2.89 (.59) is statistically
different; t (31) = 2.16, p < .038, r = .36 (medium effect). This
suggests that participants’ level of concern towards their med-
ications changed during the 12 weeks. When comparing the
baseline necessity mean scores of 2.37 (.55) with post-
intervention necessity mean scores of 2.39 (.74), no statistical
significance was evident from the t test; t (31) = .171, p > .865.
This change is consistent with an increase in adherence to
medication, suggesting that when participants’ level of con-
cern is decreased, they are more likely to adhere to their
treatment.
Percentage Rating of Each Question Within the BMQ
Table 5 presents baseline and post-intervention self-reported
participant measures for the Beliefs About Medication
Questionnaire. Interestingly, the results indicate that 66% of
participants at the baseline were aware of the necessity of their
medication: Bwithout my medication I would become ill.^
This suggests that they agree that their health is dependent
on their medication. Understanding the links between their
health and medication increased post-intervention, with 71%
of participants reporting that their health was reliant on their
medication intake.
Table 3 BMQ extracts of the different text messages which were sent to participants
BMQ scale Example text messages
Low personal control BControl your Crohn’s, do not let it control you^
High personal control BI am doing my best to cope with my Crohn’s^
Low treatment control BUsing medication reminders can help you control Crohn’s disease^
High treatment control BBeing in control of your medication means you are likely to benefit from symptom reduction^
Low concern BStudies have shown that patients’ quality of life worsens during relapse^
High concern BWorrying rarely helps people to come up with solutions. Your worrying just goes in circles^
Low understanding BDo not worry your medication may not work immediately it can take up to 3–6 months before
you start to feel improvements^
High emotional response to illness BMaking a note of new enjoyable activities can help you to improve your quality of life^
Medication concern high BTaking medication after eating or in two smaller doses each day instead of all at once may help
reduce side effects such as vomiting and nausea^
Medication necessity low BYour medication works best when taken every day^
Table 4 Participants’ demographics characteristics (n = 32)
Variables
Ethnicity N (%)
White British 32 (39%)
Black British 3 (4%)
Pakistan 2 (2%)
Sikh 1 (1%)
Irish 1 (1%)
Gender
Female 22 (69%)
Male 10 (31%)
Age Range 25–70 years, mean 42.7 (9.16)
Year of diagnosis Range 3 months–31 years
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Concerns relating to the long-term effects of the medication
were significantly high: at baseline, 91% of participants
agreed BI sometimes worry…^ This concern was also evident
when 62% of participants agreed that Bhaving to take medi-
cine worries me.’ These worries decreased post-intervention,
however, with only 37% agreeing that they were still worried
about their medication.
Table 5 shows that a change in each domain has occurred
from baseline to-post-intervention; this suggests that sending
tailored text messages can change an individual’s beliefs sur-
rounding their medication.
Discussion
This research evaluated the efficacy of personalized tai-
lored text messages. Personalization was based on partici-
pants’ illness perceptions and medication beliefs. These
results were analyzed over a 12-week period, and baseline,
and post-test results were compared for each questionnaire
administered. A statistical analysis was carried out in order
to measure the significance of the data. The results found
that a significant change occurred over the period of
interest.
Table 5 Percentage of participants agreeing/strongly agreeing with statements from the Belief about Medication Questionnaire
N Percentage agreeing or strongly agreeing
Baseline (0 weeks) Post (12 weeks)
Necessity scale
My health, at present, depends on my medicines 32 66% 84%
My life would be impossible without my medicines 32 50% 62%
Without my medicines, I would become very ill 32 66% 71%
My health in the future will depend on my medicines 32 59% 75%
My medicines protect me from becoming worse 32 62% 87%
Concerns scale
Having to take medicines worries me 32 62% 37%
I sometimes worry about the long-term effects of my medicines 32 91% 87%
My medicines are a mystery to me 32 25% 21%
My medicines disrupt my life 32 37% 37%
I sometimes worry about becoming too dependent on my medicines 32 50% 43%
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Self-reported medication adherence was shown to improve
over the 12 weeks, with participants stating that they had
started to Bnever or rarely^ miss their medication dose.
There was no specific set of text messages for the adherence
category; instead, messages were tailored to each participant’s
specific illness and medication beliefs, and this was the ap-
proach taken throughout the study.
Results from the illness perception questionnaire were
compared pre- and post-intervention; evidently, a significant
change occurred for three domains within the IPQ, namely
concern, coherence, and treatment control. Participants’ levels
of concern surrounding their condition reduced post-interven-
tion. Coherence and treatment control increased post-interven-
tion, which suggests that participants felt more in control of
their condition, possibly as a result of the daily positive IBD
messages which enabled participants to become more aware
of the demands of their condition. The results support prior
research which posits that personal beliefs about IBD play a
significant part in the adjustment to the diagnosis (Leventhal
et al. 1992; Horne et al. 2009; Tsianou et al. 2017; Lenti and
Selinger 2017). So far, the hypothesis can be accepted, as the
results have indicated a change in adherence, illness percep-
tion, and medication beliefs. In order to offer a detailed expla-
nation of these findings, however, discussion will outline how
and why these changes may have occurred and will investi-
gate whether this was a true experimental effect and whether
these findings are consistent with the common-sense model of
illness representation.
Medication Adherence
Measuring adherence was instrumental in understanding
whether text messages were eliciting any type of behavioral
shift, particularly in terms of a change inmedication. Similarly
to the Petrie et al. (2012) study, this research has identified a
positive medication adherence trend over the period of
3 months. Participants were more likely to Bnever^ forget to
take their medication post-intervention. Although this is a
positive finding, understanding the occurrence of this shift
will help in evaluating the methodology. Earlier discussions
and the reviewed literature on adherence suggested that send-
ing targeted messages specific to the individual, instead of
gener ic messages , is genera l ly more acceptable
(Dekoekkoek et al. 2015; Head et al. 2013). Similarly, there
is a consensus that patients may not always be willing to admit
that they are not adhering to their medication. Given this,
offering an alternative strategy for identifying patients and
informing them about the benefits of medication via messag-
ing has been shown to be effective in addressing some of the
underlying concerns relating to non-adherence. Therefore, this
type of intervention can be applied to those who may not
always be in touch with their healthcare providers, and can
offer a means of challenging any pre-conceived, unconscious
assumptions regarding their medication.
Illness Perception Scale
Level of Concern
Participants’ levels of concern were measured via the illness
perception scale, and the analysis reported a significant differ-
ence over the period of 3 months. This finding was consistent
with previous research (Petrie et al. 2001). Indeed, this change
is positive, but in order to help understand why there was a
behavioral shift, we need to recognize why patients may hold
these concerns. As discussed earlier, Kelly et al. (2014) sys-
tematic review stated that the most common themes for non-
adherence was patients’ knowledge and attitude surrounding
their medication, and the negative beliefs they associated with
their treatment, including about side effects of the medication.
They found that these perceived concerns influenced patients’
decisions to become non-adherent. Similarly, Moser et al.
(1995) outlined some of the significant concerns held by
IBD patients, including beliefs surrounding the possibility of
having an ostomy bag, the general effects of medication, sur-
gery, the uncertain nature of the disease, and lack of energy.
With this acknowledgment, both studies recommended that
our understanding of the level of information patients have
about their condition and any disease-related concerns should
be queried and considered within clinical practice, thereby
equipping patients to feel more empowered to self-manage
their condition. These findings are consistent with Gadkari
and McHorney (2012), who also believe that removing or
altering patients preconceived negative beliefs surrounding
their medication would increase medication adherence.
This study has been able to illustrate the links between the
benefits of educating patients about their condition by reduc-
ing the number of preconceived concerns held by the individ-
uals via text message. The process of sending personalized
text messages—addressing topics such as Bthe effects of
medication^ and Bthe importance of managing your
diagnosis^—has been shown to improve and reduce signifi-
cant levels of concern.
Coherence
Participants’ coherence positively increased post-intervention;
this change suggests that respondents felt more in control of
their condition, and that receiving daily positive IBD mes-
sages enabled participants to becomemore aware of what their
condition entails. Previous research has outlined the impor-
tance of coherence, and the benefits of addressing this. The
concept of coherence is used to describe a person’s capacity to
respond to stressful situations; given the complexity of living
with IBD, personal resources and capabilities are often drawn
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upon in response to managing the condition. Given the signif-
icant increase in coherence post-intervention, we can assume
that this method of addressing motivation and tackling chal-
lenges has been successful by providing clear and coherent
information about IBD, which is an important protective fac-
tor against psychological stress. Findings such as this further
support the imperative nature of tailored text messages, as this
method opens many different communication pathways and
permits the researcher to tackle other underlying factors such
as coherence, which other methods may neglect.
Treatment Control
A lack of understanding about treatment can significantly
influence how a patient may accept their diagnosis, or ad-
here to their treatment regimen. Patients fear a loss of con-
trol over their treatment decisions, as these are mostly left
to the clinician. Therefore, taking responsibility for their
treatment can represent delicate territory for some.
Nevertheless, offering strategies to cope with and under-
stand the importance and purpose of treatment for IBD can
help to empower patients to feel a part of the process,
instead of merely receiving and following orders.
Effective management to change beliefs from BI am not
in control of my treatment^ to BI know I can make the right
treatment decisions^ can be empowering and motivating.
The results from this study found a significant increase in
treatment control after the 12 weeks. Participants felt more
involved with their treatment, through understanding how
their treatment was helpful in the short- and long-term,
together with outlining the consequences of non-adher-
ence. This was yet another positive finding, which supports
the idea of sending targeted text messages.
Beliefs About Medication Scale
As discussed earlier, Tsianou et al. (2017) suggested that the
most important factor affecting compliance with medication
regimens is how one feels about the drugs they are prescribed,
which then contributes to how successful they are in following
the doctor’s advice. This is of interest, as this study has sup-
ported this assumption and confirmed that patients’ levels of
concern around medication can be addressed through some
types of interventional or conversation process. In practice,
this should alter the concern threshold and increase patients’
awareness of necessity for their treatment. Although there was
a significant change in levels of concern around medication,
this was not transferred to heightened awareness of the neces-
sity for treatment. Over the period of 12 weeks, the results
found no significant change in participants’ beliefs about the
necessity of treatment. This is not to say that the text messages
did not address this; however, another explanation could be
that at baseline, participants’ understanding that their
treatment was necessary for their condition was already high,
which is why a change did not occur.
This research aimed to uncover, challenge, and change the
cognitive representation of IBD using text messages. An in-
crease in treatment control and coherence represents the emer-
gence of positive beliefs about controllability and personal
understanding of IBD. Addressing these variables in isolation
without the other measures has already shown a positive
change with this technique. When comparing the outcomes
of this study in combination, however, we can agree that this
methodology has been positive and can confirm that offering
non-conventional alternative strategies via technological inter-
ventions can be effective in targeting hard-to-reach patients
across different regions. Therefore, this study has added to
the IBD literature and has re-confirmed the findings of Petrie
et al. (2001) in their asthma intervention. This transferable
method can be applied to different therapy areas and offers
the possibility of a significant change in attitudes and beliefs
surrounding medication and diagnosis. Mobile interventions
are scalable and cost-effective, and do not require face-to-face
interactions for participants or researchers. This form of a
narrative approach permits the researcher to devise effective
and meaningful messages and encourages the delivery of in-
formative health messages.
One participant observed: BI enjoyed taking part in this
study, and I honestly felt the last text was a really positive
boost (Byou are doing your best to manage Crohn’s). At the
time of receiving this, I was flaring more than I had been and it
really made me feel positive.^ This suggests that the text mes-
sages were not only supportive in encouraging medication
intake, but that participants also utilized the messages as a
source of positive encouragement and reinforcement. A rec-
ommendation to test this method in other chronic conditions
can be considered; an extension of this study can also be
suggested. There are, of course, other variables that could be
introduced within this study design, such as quality of life
measurements and or motivational measures of self-efficacy,
in order to test whether the messages have increased intrinsic
motivation and if this change can improve participants’ qual-
ity of life.
Mobile health is steadily increasing within the healthcare
domain; studies such as this can help educate and enforce
change. These findings can contribute considerably to the de-
velopment and evaluation of other TMI interventions and ver-
ify the importance of developing subtle, innovative techniques
that are based in health psychology theories.
Conclusions
This is the first study evaluating the effects of tailored text
messages with IBD patients. Previous research has focused
on asthma patients, as previously discussed, and has
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demonstrated a positive behavioral shift in beliefs and per-
ceptions (Petrie et al. 2001). Studies that have adopted text
messaging within their design have consistently shown im-
proved health behavior outcomes, such as quality of life
improvements, increases in health literacy, decreases in
concerns about medication, and improvements in self-
management.
The outcome demonstrates the efficacy of mobile text mes-
sages and shows positive results in eliciting change in prior
beliefs and perceptions about individuals’ diagnoses and con-
ditions. However, this process also acknowledges the weak-
nesses in this study, for instance medication compliance was
based on patients’ self-report; adaption of this study should
find alternative ways to collect data and not be reliant on self-
report. The pilot study acquired a small sample size, and ex-
tending this for future studies can verify the results and be
more representative to the general population.
Nevertheless, this inexpensive and useful tool, if used cor-
rectly, can make a positive impact in areas such as illness
perceptions, medication beliefs, and levels of medication ad-
herence for IBD patients. This evaluation has shown that tai-
loring text messages, although time-consuming, does in fact
elicit positive change in areas where other techniques or
methods may not be as effective.
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